Pick almost any consumer health category and trace it back thirty years. Most look unrecognizable. New mechanisms, new delivery systems, new understanding of the underlying biology, and a steady turnover of what’s considered standard.
Now do the same with hair loss. The picture is very different. The category’s best-known actives have been around for decades, and much of what’s marketed today is a variation on chemistry that was settled a long time ago. Packaging has changed. Claims have gotten louder. The science underneath has barely moved.
Qing Yao spent a while thinking about why. She’s a co-founder of RE:YOU, a luxury biotech haircare brand aimed at women dealing with visible thinning and changes in hair vitality, and her diagnosis of the industry’s stall has two parts.
The first is that the category settled early. Once a handful of treatments became the accepted answer, the commercial incentive to look for a better one weakened considerably. Brands could compete on marketing rather than on discovery, which is cheaper and faster and doesn’t require anyone to fund a research program with an uncertain payoff.
The second is who the existing answers were built for. Hair loss research was organized around male pattern baldness, and women’s products were largely derived from that work rather than developed independently. Female hair thinning presents differently, tends to be diffuse rather than patterned, and frequently overlaps with other physiological changes. Adapting a product designed for a different problem is a reasonable shortcut, but it’s still a shortcut, and the category treated it as a conclusion.
Yao’s argument is that science has moved even if the products haven’t. Molecular research into hair biology has produced a much richer picture over the past decade than the shelf reflects. What’s been missing is a company willing to build on the newer work instead of licensing the old.
RE:YOU is her attempt at that. The company describes itself as rooted in advanced molecular discovery, with the clinical work as its foundation rather than its marketing angle.
There’s a second gap Yao points to that has nothing to do with laboratories. Hair regimens are notorious for poor adherence. They ask for time, tolerate mess, and demand a routine that most people abandon within a couple of months. The industry has generally treated this as a customer problem. Yao treats it as a product problem, which means the experience of using something — how quickly it absorbs, how it feels, whether it fits into a morning that’s already full — belongs in the development process alongside the formulation.
That combination is unusual mostly because it shouldn’t be. A category that hasn’t produced a real breakthrough in decades has plenty of room for companies willing to work on both halves at once.
Whether the incumbents respond is the interesting part. Comfortable industries tend not to
